Abstract
Vascular cognitive impairment (VCI) describes a spectrum of cognitive changes occurring secondary to damage of the large and small vessels that supply blood to the brain. VCI has been recognized as the second most common cause of dementia and as the most common pathological comorbidity of Alzheimer’s disease. The pathogenesis of VCI appears to be heterogeneous, involving neurodegenerative mechanisms that remain to be fully understood. Stroke and vascular risk factors interfere with many processes subserved by the cerebral vasculature, maintaining cerebral homeostasis (for instance, maintaining and augmenting blood flow, oxygen, glucose supply), providing a structural and chemical barrier between the peripheral circulation and the brain parenchyma, serving intricate immunological functions, and providing a neurogenic niche for brain tissue repair. This chapter discusses the known and theoretical pathophysiological background of VCI, focusing on stroke and disruption of the neurovascular unit (NVU), which contribute to defects in neurotransmitter systems and to disruption of large-scale functionally co-activating networks, which contributes to cognitive deficits and decline.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80(4):844–66.
Armulik A, Genové G, Mäe M, et al. Pericytes regulate the blood–brain barrier. Nature. 2010;468(7323):557–61.
Ramirez J, Berezuk C, McNeely AA, et al. Imaging the perivascular space as a potential biomarker of neurovascular and neurodegenerative diseases. Cell Mol Neurobiol. 2016;36(2):289–99.
Chung C-P, Chou K-H, Chen W-T, et al. Strictly lobar cerebral microbleeds are associated with cognitive impairment. Stroke. 2016;47(10):2497–502.
Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci. 2011;12(12):723–38.
Marnane M, Al-Jawadi OO, Mortazavi S, et al. Periventricular hyperintensities are associated with elevated cerebral amyloid. Neurology. 2016;86(6):535–43.
Makedonov I, Black SE, MacIntosh BJ. Cerebral small vessel disease in aging and Alzheimer’s disease: a comparative study using MRI and SPECT. Eur J Neurol. 2013;20(2):243–50.
MacIntosh BJ, Swardfager W, Robertson AD, et al. Regional cerebral arterial transit time hemodynamics correlate with vascular risk factors and cognitive function in men with coronary artery disease. Am J Neuroradiol. 2015;36(2):295–301.
Keith J, Gao FQ, Noor R, et al. Collagenosis of the deep medullary veins: an underrecognized pathologic correlate of white matter hyperintensities and periventricular infarction? J Neuropathol Exp Neurol. 2017;76(4):299–312.
Kisler K, Nelson AR, Montagne A, et al. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci. 2017;18(7):419–34.
Kisler K, Nelson AR, Rege SV, et al. Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain. Nat Neurosci. 2017;20(3):406–16.
Yemisci M, Gursoy-Ozdemir Y, Vural A, et al. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med. 2009;15(9):1031–7.
Swardfager W, Yu D, Scola G, et al. Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease. Neurobiol Aging. 2017;59:91–7.
van Exel E, de Craen AJM, Remarque EJ, et al. Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function. Neurology. 2003;61(12):1695–701.
Toth P, Tucsek Z, Tarantini S, et al. IGF-1 deficiency impairs cerebral myogenic autoregulation in hypertensive mice. J Cereb Blood Flow Metab. 2014;34(12):1887–97.
Rosenberg GA. Extracellular matrix inflammation in vascular cognitive impairment and dementia. Clin Sci. 2017;131(6):425–37.
Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17(7):796–808.
Saggu R, Schumacher T, Gerich F, et al. Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia. Acta Neuropathol Commun. 2016;4(1):76.
Cai M, Lee JH, Yang EJ. Bee venom ameliorates cognitive dysfunction caused by neuroinflammation in an animal model of vascular dementia. Mol Neurobiol. 2017;54(8):5952–60.
Swardfager W, Winer DA, Herrmann N, et al. Interleukin-17 in post-stroke neurodegeneration. Neurosci Biobehav Rev. 2013;37(3):436–47.
Kim J-Y, Kim N, Yenari MA. Mechanisms and potential therapeutic applications of microglial activation after brain injury. CNS Neurosci Ther. 2015;21(4):309–19.
Choi SS, Lee HJ, Lim I, et al. Human astrocytes: secretome profiles of cytokines and chemokines. PLoS One. 2014;9(4):e92325.
Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment: a critical update. Front Aging Neurosci. 2013;5:17.
Muir RT, Lam B, Honjo K, et al. Trail making test elucidates neural substrates of specific poststroke executive dysfunctions. Stroke. 2015;46(10):2755–61.
Liu Q, Zhu Z, Teipel SJ, et al. White matter damage in the cholinergic system contributes to cognitive impairment in subcortical vascular cognitive impairment, no dementia. Front Aging Neurosci. 2017;9:47.
Gao F, Pettersen JA, Bocti C, et al. Is encroachment of the carotid termination into the substantia innominata associated with its atrophy and cognition in Alzheimer’s disease? Neurobiol Aging. 2013;34(7):1807–14.
Kalaria RN. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease. Acta Neuropathol. 2016;131(5):659–85.
Black S, Roman GC, Geldmacher DS, et al. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke. 2003;34(10):2323–30.
Lim J-S, Kim N, Jang MU, et al. Cortical hubs and subcortical cholinergic pathways as neural substrates of poststroke dementia. Stroke. 2014;45(4):1069–76.
McNeely AA, Ramirez J, Nestor SM, et al. Cholinergic subcortical hyperintensities in Alzheimer’s disease patients from the Sunnybrook Dementia Study: relationships with cognitive dysfunction and hippocampal atrophy. J Alzheimers Dis. 2015;43(3):785–96.
Lanctôt KL, O’Regan J, Schwartz Y, et al. Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease. Psychosomatics. 2014;55(1):61–8.
Kirvell SL, Elliott MS, Kalaria RN, et al. Vesicular glutamate transporter and cognition in stroke: a case-control autopsy study. Neurology. 2010;75(20):1803–9.
Mijajlović MD, Pavlović A, Brainin M, et al. Post-stroke dementia—a comprehensive review. BMC Med. 2017;15(1):11.
Gold AB, Herrmann N, Swardfager W, et al. The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. J Neuroinflammation. 2011;8(1):17.
Rezvani AH. Involvement of the NMDA system in learning and memory. In: Levin ED, Buccafusco JJ, editors. Animal models of cognitive impairment. Boca Raton, FL: CRC Press/Taylor & Francis; 2006.
Palomar FJ, Suarez A, Franco E, et al. Abnormal sensorimotor plasticity in CADASIL correlates with neuropsychological impairment. J Neurol Neurosurg Psychiatry. 2013;84(3):329–36.
Wang L, Zang Y, He Y, et al. Changes in hippocampal connectivity in the early stages of Alzheimer’s disease: evidence from resting state fMRI. NeuroImage. 2006;31(2):496–504.
Sun Y, Qin L, Zhou Y, et al. Abnormal functional connectivity in patients with vascular cognitive impairment, no dementia: a resting-state functional magnetic resonance imaging study. Behav Brain Res. 2011;223(2):388–94.
Yi L, Wang J, Jia L, et al. Structural and functional changes in subcortical vascular mild cognitive impairment: a combined voxel-based morphometry and resting-state fMRI study. PLoS One. 2012;7(9):e44758.
Broyd SJ, Demanuele C, Debener S, et al. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev. 2009;33(3):279–96.
Fernández PJ, Campoy G, GarcĂa Santos JM, et al. Is there a specific pattern of attention deficit in mild cognitive impairment with subcortical vascular features? Evidence from the attention network test. Dement Geriatr Cogn Disord. 2011;31(4):268–75.
Silbert LC, Nelson C, Howieson DB, et al. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology. 2008;71(2):108–13.
Biesbroek JM, Weaver NA, Hilal S, et al. Impact of strategically located white matter hyperintensities on cognition in memory clinic patients with small vessel disease. PLoS One. 2016;11(11):e0166261.
Ishikawa H, Meguro K, Ishii H, et al. Silent infarction or white matter hyperintensity and impaired attention task scores in a nondemented population: the Osaki-Tajiri project. J Stroke Cerebrovasc Dis. 2012;21(4):275–82.
Santiago C, Herrmann N, Swardfager W, et al. White matter microstructural integrity is associated with executive function and processing speed in older adults with coronary artery disease. Am J Geriatr Psychiatry. 2015;23(7):754–63.
Teipel SJ, Bokde ALW, Meindl T, et al. White matter microstructure underlying default mode network connectivity in the human brain. NeuroImage. 2010;49(3):2021–32.
Tuladhar AM, Reid AT, Shumskaya E, et al. Relationship between white matter hyperintensities, cortical thickness, and cognition. Stroke. 2015;46(2):425–32.
Nestor SM, Mišić B, Ramirez J, et al. Small vessel disease is linked to disrupted structural network covariance in Alzheimer’s disease. Alzheimers Dement. 2017;13(7):749–60.
Swardfager W, Cogo-Moreira H, Masellis M, et al. The effect of white matter hyperintensities on verbal memory; mediation by temporal lobe atrophy. Neurology. 2018;90(8):e673–82.
Acknowledgments
We would like to gratefully acknowledge the support from our colleagues, Sabrina Adamo and Fuqiang Gao from Sunnybrook Research Institute, for their contribution to the processing and labeling of the MR images. W.S. gratefully acknowledges support from the Alzheimer’s Association (US), Brain Canada, The Canadian Partnership for Stroke Recovery, Sunnybrook Health Sciences Centre Department of Psychiatry, Sunnybrook Research Institute Hurvitz Brain Sciences Program, and the University of Toronto Department of Pharmacology and Toxicology. S.E.B. gratefully acknowledges financial and salary support from the Fondation Leducq, Canadian Institutes of Health Research (#125740 & #13129), Heart and Stroke Foundation Canadian Partnership for Stroke Recovery, Hurvitz Brain Sciences Research Program at Sunnybrook Research Institute, and the Linda C. Campbell Foundation. S.E.B. would also like to thank the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre Department of Medicine, and the Brill Chair Neurology, University of Toronto, for financial and salary support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Yu, D., Swardfager, W., Black, S.E. (2020). Pathophysiology of Vascular Cognitive Impairment (I): Theoretical Background. In: Lee, SH., Lim, JS. (eds) Stroke Revisited: Vascular Cognitive Impairment. Stroke Revisited. Springer, Singapore. https://doi.org/10.1007/978-981-10-1433-8_7
Download citation
DOI: https://doi.org/10.1007/978-981-10-1433-8_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-1432-1
Online ISBN: 978-981-10-1433-8
eBook Packages: MedicineMedicine (R0)